CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 160 enrolled
Drug / intervention
Prospective Observationalother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01440049
NCT01440049N/ACompleted

Assessment Of Follow-Up Methods For Patients Treated In The Long-Term With A Specific Aldosterone Receptor Antagonist

Pfizer·observational·Posted Sep 26, 2011·Updated Dec 19, 2018

In Brief

An observational study evaluating Prospective Observational for Left Ventricular Dysfunction Post Myocardial Infarction. Completed, enrolled 160 participants.

Detailed Summary

On a population of patients followed by an office-based cardiologist and treated with eplerenone, the objectives of the survey are: * To describe the characteristics of the population treated. * To describe the methods of use of eplerenone (posology, duration of treatment, medicinal combinations). * To describe the follow-up methods of the treatment. * To describe the possible interruptions of the treatment

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 26, 2011
Enrollment StartSep 1, 2008
Primary CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 14.8 years ago

Interventions

Prospective Observationalother

this is an observational study non interventional